This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...

First-in-class, covalent, oral small molecule inhibitor targeting IRF5IRF5 is a genetically validated driver of autoimmune diseases, including ...

Psoriasis, affecting over a million people across Britain, may put those living with the condition and their family members ...

The Congress of Clinical Rheumatology annual meetings have over the past 43 years grown from a few doctors in a basement in ...

"On chronic illness flare days, Daddy pretends to be a 'monster' chasing and mommy is the 'safe space' where kiddos can run ...

Learn more about whether AnaptysBio, Inc. or TG Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, ...

At 54 weeks in the STOP-HS1 and STOP-HS2 trials, up to 71.4% of patients taking povorcitinib achieved at least a 50% reduction from baseline in the total abscess and inflammatory ...

Learn more about whether AnaptysBio, Inc. or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor ...

To access the audio webcast and subsequent archived recording of this and other company presentations, please visit the Investors section of Artiva’s website. The archived audio webcast will remain ...

Discusses Proposed Acquisitions of Tubulis, Ouro and Arcellx and Strategic Pipeline Expansion April 7, 2026 4:30 PM ...

Detailed price information for Incannex Healthcare Inc ADR (IXHL-Q) from The Globe and Mail including charting and trades.

Geetanjali Om Parkash, 59, wins Mrs International World Classic 2026 in Kuala Lumpur, becoming first Indian titleholder, also ...